Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients

PURPOSE: This study aimed to determine the oncologic efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment concurrent with chemotherapy in a neoadjuvant setting. METHODS: A retrospective analysis was performed on 332 cases of invasive breast cancer in patients who were <40 years old...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Breast Cancer
Main Authors: Kim, Hee Jeong, Yoon, Tae-In, Chae, Hee Dong, Kim, Jeong Eun, Chae, Eun Young, Yu, Jong Han, Sohn, Guiyun, Ko, Beom Seok, Lee, Jong Won, Son, Byung Ho, Ahn, Sei Hyun
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Breast Cancer Society 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4705088/
https://ncbi.nlm.nih.gov/pubmed/26770243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2015.18.4.365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados